CEPI commits $30m to support updated Zaire ebola virus vaccine, boost affordability
The Coalition for Epidemic Preparedness Innovations (CEPI) has committed $30 million to support an updated Zaire ebolavirus vaccine aimed at improving affordability, accessibility, and sustainability for low- and middle-income countries (LMICs). The collaboration brings together CEPI, global biopharmaceutical company MSD,
Follow Us on Google News